Financial results - SFERLEMED S.R.L.

Financial Summary - Sferlemed S.r.l.
Unique identification code: 40366273
Registration number: J05/6/2019
Nace: 8621
Sales - Ron
104.658
Net Profit - Ron
41.307
Employees
2
Open Account
Company Sferlemed S.r.l. with Fiscal Code 40366273 recorded a turnover of 2024 of 104.658, with a net profit of 41.307 and having an average number of employees of 2. The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Sferlemed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 2.841 10.647 34.845 59.593 85.842 104.658
Total Income - EUR - - - - 2.841 10.647 34.846 59.594 85.848 104.727
Total Expenses - EUR - - - - 683 2.518 23.977 39.794 48.454 60.749
Gross Profit/Loss - EUR - - - - 2.158 8.129 10.869 19.800 37.394 43.977
Net Profit/Loss - EUR - - - - 2.073 7.825 10.514 19.294 36.664 41.307
Employees - - - - 0 0 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 22.6%, from 85.842 euro in the year 2023, to 104.658 euro in 2024. The Net Profit increased by 4.848 euro, from 36.664 euro in 2023, to 41.307 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Sferlemed S.r.l.

Rating financiar

Financial Rating -
SFERLEMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Sferlemed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Sferlemed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Sferlemed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Sferlemed S.r.l. - CUI 40366273

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 41.972 32.196 22.222 12.839
Current Assets - - - - 2.849 10.143 9.498 23.485 43.770 81.575
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 843 930 3.710 4.110 13.904 708
Cash - - - - 2.006 9.213 5.788 19.375 29.867 80.867
Shareholders Funds - - - - 2.115 9.900 20.195 33.346 57.239 90.272
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 734 243 31.276 22.335 17.654 4.142
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8621 - 8621"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 81.575 euro in 2024 which includes Inventories of 0 euro, Receivables of 708 euro and cash availability of 80.867 euro.
The company's Equity was valued at 90.272 euro, while total Liabilities amounted to 4.142 euro. Equity increased by 33.353 euro, from 57.239 euro in 2023, to 90.272 in 2024.

Risk Reports Prices

Reviews - Sferlemed S.r.l.

Comments - Sferlemed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.